Literature DB >> 28215646

An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme.

Sergio Zavala-Vega1, Graciela Castro-Escarpulli2, Hector Hernández-Santos3, Citlatepetl Salinas-Lara4, Icela Palma5, Juan Manuel Mejía-Aranguré6, Noemí Gelista-Herrera4, Daniel Rembao-Bojorquez4, Sara A Ochoa7, Ariadnna Cruz-Córdova7, Juan Xicohtencatl-Cortes7, Gabriel Uribe-Gutiérrez3, José Arellano-Galindo8.   

Abstract

Several risk factors are involved in glioblastoma, including cytomegalovirus (CMV). This research was carried out to determine the rate of CMV infection, as well as HSV 1/2 and EBV in brain tissue, in patients with glioblastomamultiforme (GBM). The tissues were tested using immunohistochemistry, PCR, in situ hybridization and real-time PCR. At least, one HHV was detected in 21/29 (72%) patients as follows: single infections with HSV-1/2 in 4/21 (19%), EBV in 6/21 (28.6%) and CMV in 1/21 (4.8%). Mixed viral infection, HSV-1/2 and EBV were detected in 4/21 patients (19%), CMV and EBV in 5/21 (23.8%), and HSV-1/2, EBV, and CMV in 1/21. The CMV viral load ranged from 3×102 to 4.33×105 genome/100ng of tissue. Genotype based on CMV gB was 3/7 where 2/3 was gB1 and 1/3 gB4. HSV, EBV and CMV were frequently found in brain tissues, more in mix in a population reported as highly seropositive.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cytomegalovirus; Epstein–Barr; Glioblastomamultiforme; HHVs; Herpes; Viral infection

Mesh:

Year:  2016        PMID: 28215646     DOI: 10.1016/j.prp.2016.12.006

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Authors:  Ravindra Pramod Deshpande; Manas Panigrahi; Chandrasekhar Y B V K; Phanithi Prakash Babu
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

2.  As Evidence-Based Tumorigenic Role of Epstein-Barr Virus miR-BART1-3p in Neurological Tumors.

Authors:  Mohammad Karimzadeh; Alireza Tabibzadeh; Mohsen Moghoofei; Saeedeh Abbasi; Javid Sadri Nahand; Farzin Sadeghii; Mohammad Hadi Karbalaie Niya; Hossin Keyvani; Farah Bokharaei-Salim; Moein Esghaei; Maryam Esghaei
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

3.  Molecular Investigation of Human Cytomegalovirus and Epstein-Barr virus in Glioblastoma Brain Tumor: A Case-Control Study in Iran

Authors:  Hadi Ghaffari; Ahmad Tavakoli; Mohammad Faranoush; Ali Naderi; Seyed Jalal Kiani; Alireza Sadeghipour; Davod Javanmard; Mohammad Farahmand; Saied Ghorbani; Farnoush Sedaghati; Seyed Hamidreza Monavari
Journal:  Iran Biomed J       Date:  2021-11-01

Review 4.  The Association of Human Herpesviruses with Malignant Brain Tumor Pathology and Therapy: Two Sides of a Coin.

Authors:  Evita Athanasiou; Antonios N Gargalionis; Fotini Boufidou; Athanassios Tsakris
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 5.  Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact?

Authors:  Saghir Akhtar; Semir Vranic; Farhan Sachal Cyprian; Ala-Eddin Al Moustafa
Journal:  Front Oncol       Date:  2018-04-20       Impact factor: 6.244

6.  Evodiamine alleviates severe pneumonia induced by methicillin-susceptible Staphylococcus aureus following cytomegalovirus reactivation through suppressing NF-κB and MAPKs.

Authors:  Xin Chen; Shujun Zhou; Hui Li
Journal:  Int J Mol Med       Date:  2018-10-11       Impact factor: 4.101

Review 7.  Epstein-Barr Virus and Neurological Diseases.

Authors:  Nan Zhang; Yuxin Zuo; Liping Jiang; Yu Peng; Xu Huang; Lielian Zuo
Journal:  Front Mol Biosci       Date:  2022-01-10

Review 8.  Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments.

Authors:  Jaehyun Ahn; Christopher Shin; Yeo Song Kim; Jae-Sung Park; Sin-Soo Jeun; Stephen Ahn
Journal:  Brain Tumor Res Treat       Date:  2022-07

9.  Viral oncogenesis in tumours of the central nervous system: reality or random association? A retrospective study on archived material.

Authors:  Dorel Eugen Arsene; Elena Milanesi; Maria Dobre
Journal:  J Cell Mol Med       Date:  2022-02-02       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.